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Abstract
Backgroud: To determine whether the professional Omron HBP-1300 blood pressure (BP) monitor meets American
Association for the Advancement of Medical Instrumentation (AAMI) accuracy standards in Chinese children and adults.
Method: According to the AAMI protocol, simultaneous auscultatory measurements by two observers using a mercury
manometer were obtained in participants using the Omron HBP-1300. Triple measurements were obtained after a
minimum 5-min rest with a 1-min interval between adjacent measurements.
Results: A total of 85 participants submitted to 255 doctor-measured BP and 255 successful professional monitor
readings. The initial auscultation systolic BP was <100 mmHg in 25 participants (29.4 %), 100–160 mmHg in 53
participants (62.4 %), and >160 mmHg in seven participants (8.2 %). All of the simultaneous measurements agreed to
within ±10 mmHg, while 95 % agreed to within ±4 mmHg for both systolic and diastolic BP, and the consistency
between two observers was satisfactory. The difference between the devices was -1.3 ± 3.6 mmHg for systolic BP
and 0.7 ± 3.8 mmHg for diastolic BP and by AAMI method 1, which met this guideline. The average difference
between two devices by AAMI method 2 was 1.4 ± 3.2 mmHg for systolic BP and 1.0 ± 3.9 mmHg for diastolic BP,
which met this guideline.
Conclusion: The professional BP monitor Omron HBP-1300 is desirable for measuring the BP for Chinese children
and adults.
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Background
Many hypertension survey protocols use automatic digital
devices for measurements since they have no observer
error and require no strict training. Clinicians are increas-
ingly developing confidence that automated blood pressure
(BP) device readings are comparable to those of ausculta-
tory manual devices [1, 2]. Meanwhile, trial evidence indi-
cates that even small differences of 2–4 mmHg in systolic
BP (SBP) are clinically important, thus accurate measure-
ments are vital. A BP-measuring device that can pass the
American Association of Medical Instrumentation (AAMI)
standard testing [3] with reliable accuracy would be a
desirable one for either clinic or research. The professional
blood pressure monitor Omron HBP-1300 might poten-
tially be a new monitor meeting that need.
Methods
Introduction of the AAMI standard
The standard advises testing over a range of arm sizes and
BP. Subjects should undergo a variety of BP readings to
determine whether the device is accurate for all BP ranges.
All device cuff sizes to be marketed should be studied.
The AAMI standard requires to include data of all
participants who entered into the validation study, an
explanation of the technical problems preventing inclu-
sion of the required data, and a full explanation of and the
reasons for data exclusion. For inter-observer compari-
sons, the AAMI standard states that all of simultaneous
measurements should vary within ±10 mmHg and ≥90 %
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of those measurements should vary within ±5 mmHg be-
tween different observers for both SBP and DBP. Once
the measurement meets these criteria, the average of these
measurements is used for the analysis.
The AAMI standard provides two methods for accuracy
determination on automated sphygmomanometers in
which the auscultatory method is used as a reference stand-
ard. Method 1 requires a minimum of 255 observations
from ≥85 participants. If a participant contributes fewer
than three data sets (paired observer and device measure-
ments), additional participants are tested to reach a mini-
mum of 255 observations. The AAMI standard requires
that the variability of the automated device for both SBP
and DBP should be within 4 (mean) ± 8 (SD) mmHg.
Method 2 was developed because of concerning that
method 1 might qualify a device with clinically unaccept-
able error in terms of allowing the upper limit of both the
mean difference and the SD. Method 2 uses the average of
three measurements for each participant to replicate the
use of multiple measurements to establish a diagnosis of
hypertension [4, 5].
Human subjects
The Chinese Capital Institutes of Pediatrics completed the
collection of data for 35 children and merged them with
the data of 50 adults and adolescents provided by the
Shanghai Institute of Hypertension. Adult subjects were
mostly outpatients and inpatients of Ruijin Hospital. The
pediatric and adolescent subjects were mostly recruited
from routine checkups performed in the school or com-
munity. Participants with known significant heart rhythm
disorders were excluded.
Human observers
All observers were pediatricians or doctors whose accur-
acy and reliability in BP measurement in children and
adults were verified through strict training and passing
of a strict inspection.
BP measurements
Pairs of observers were trained to perform auscultatory
measurements by reporting of the first and fifth Korotkoff
sounds as SBP and DBP in adults and the first and fourth
Korotkoff sounds as SBP and DBP in children < 12 years
old. The testing was performed in a warm and quiet room.
Each participant was seated with the back supported, legs
uncrossed, and feet on the floor. The observers measured
the circumference at the midpoint of the arm and selected
an appropriate cuff, the width of which was as close as
possible to 40 % of the arm circumference. The cuff tub-
ing had a three-way stopcock inserted to alternate the
manual auscultatory readings. After each subject rested
for at least 15 min, BP was measured on the left upper
arm at the level of the heart and the lower arm passively
supported. The interfacing two measurements were sepa-
rated by at least 1 min intervals. Heart rate was recorded in
beats/min at each visit. Then the button of start was
pressed and the measurements started automatically [6].
The cuffs were applied to the left upper arm with the
cuff artery marker positioned over the point of brachial ar-
tery palpation. The observers used a calibrated aneroid
sphygmomanometer (Diving Fish upper arm type mercury
desktop device; Jiangsu Diving Fish Medical Equipment
Co. LTD.). The test devices underwent identical calibra-
tion procedures. The stethoscope had dual earpieces to
allow simultaneous auscultation by both trained observers.
The observers were blinded from each other and from the
device during the BP measurements. If the readings from
different observers varied >4 mmHg, the measurements
was repeated until the variability was less than 4 mmHg.
Studies were stopped or rejected if subjects had
arrhythmia, could not sit still for the study. Studies were
also excluded if the average systolic readings from differ-
ent measurements differed by >10 mmHg or the diastolic
reading varied by >5 mmHg after several attempts as re-
quired in the protocol.
Protocol
The protocol defined in ANSI/AAMI/ISO81060-2:2013 re-
quirement [7] was used in this study. An initial and
stabilization manual BP measurement was performed for
BP classification. Subsequent automated manual readings
were alternated with at least 1 min separating consecutive
measurements. Each participant underwent at least three
pairs of automated vs. manual readings. The variability of
SBP or DBP values between two observers should be ≤5
mmHg. The two observers’ readings for each measurement
were averaged before comparison with the corresponding
paired measurement by the automated device. The device
should be documented to have passed the ANSI/AAMI/
ISO81060-2:2013 requirement through the data analysis.
Test devices
The HBP-1300 Professional Blood Pressure Monitor is
easy to use and has a durable design that includes a
built-in handle that makes it easily portable. It is de-
signed for use in professional settings and is clinically
proven to produce fast and reliable results. The monitor
is compatible with a series of wipe-clean GS cuffs ran-
ging from SS (12–18 cm) to XL (42–50 cm). It comes
with an AC adapter as well as a rechargeable battery
pack. The device is fitted with a shock-proof bumper
that protects it from accidental damage and comes with
a fully automatic oscillometric and manual auscultatory
mode. It is possible to manually adjust the inflation pres-
sure to improve patient comfort.
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Statistics
The data were recorded on paper and subsequently trans-
ferred into a database built using Epidata software. The
statistics were calculated by SPSS 20.0 and Medcalc soft-
ware. Bland-Altman plots were constructed with average
observer SBP or DBP values on the x-axis and Spot error
values on the y-axis, and the figures show the ±1.96 SD
limits.
Ethics statement
Written informed consent was obtained from each partici-
pant and/or their parents or guardians. The study protocol
was approved by the Institutional Review Board and
Ethics Committee of Capital Institute of Pediatrics, China.
Results
A total of 85 participants (49 males, 58 %) were re-
cruited into the study, and there were 255 valid paired
comparisons. No data points were eliminated during
the analyses; hence, there were 255 data sets. The aver-
age age was 25.9 ± 15.6 years. The characteristics of the
participants are shown in Table 1. Dataset is seen in
Additional file 1.
There were 5 size cuffs provided to Omron HBP-1300
Professional Blood Pressure Monitor in the market. The
cuff range, cuff size labels, and the numbers of children
and adults in each category were presented in Table 2.
The initial auscultation SBP was <100 mmHg in 25
participants (29.4 %), 100–160 mmHg in 53 partici-
pants (62.4 %), and >160 mmHg in seven participants
(8.2 %). The initial DBP was <60 mmHg in 23 participants
(27.1 %), >100 in nine participants (10.6 %), and ≥85
mmHg in 53 participants (62.4 %). The arm circumference
was <25 cm for 46 participants, 25–30 cm for 25 partici-
pants, and >35 cm for 12 participants. There were twice
as many patients as the number required for minimal
compliance with the AAMI protocol.
Error statistics
The spot device mean SBP error was -1.3 ± 3.6 mmHg:
84.7 % of the error readings were within ±4 mmHg, 98 %
were within ±5 mmHg, and 100 % were within ±10 mmHg.
All SBP values passed AAMI requirements. For DBP, the
mean error was 0.7 ± 3.8 mmHg: 85.9 % of the DBP errors
were within ±4 mmHg, 98.4 % were within ±10 mmHg,
and 100 % were within ±15 mmHg. All the values exceeded
the AAMI minimum requirements (passed method 1). The
average difference between observers and the device by the
AAMI method 2 was 1.4 ± 3.2 mmHg for SBP and 1.0 ± 3.9
mmHg for DBP, which met this guideline.
Bland-Altman plots
Bland-Altman plots were constructed with average ob-
served SBP or DBP values on the x-axis and spot error
values on the y-axis (Figs. 1 and 2). The figures show ±1.96
SD limits. No pattern of BP underestimation or overesti-
mation is discernable from the data distribution.
Discussion
The professional HBP-1300 device was tested against a
population of adults and children to improve researchers’
and clinicians’ confidence that the device would give
excellent results in an epidemic survey and in clinics in
China. In the current study, the device met or exceeded
the testing requirements of the AAMI American National
Standard.
Table 1 Characteristics of the study population
Mean ± SD Range
Age (years) 25.9 ± 15.6 4-72
Male/female 49:36:00 -
Pulse (beats/minute) 82 ± 15 51-120
Arm circumference (cm) 25.8 ± 8.3 15.7-47
Systolic blood pressure(mmHg) 119 ± 28 84-210
Diastolic blood pressure(mmHg) 72 ± 18 42-120









R 12-18 SS 9 22
R 17-22 S 9 13
M 22-32 M 9 25
L 32-42 L 9 18
XL 42-50 XL 9 9
Fig. 1 Agreement between the test and reference methods for systolic
pressure. The X axis in Fig. 1 represents the mean of systolic blood
pressure of the HBP-1300 Professional Blood Pressure Monitor and
the sphygmomanometer; and the Y axis represents the difference
between systolic blood pressure measured by HBP-1300 Professional
Blood Pressure Monitor and the systolic blood pressure measured by
the sphygmomanometer
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Since hypertension is a chronic disease and BP is affected
by various factors [8], accurate BP measurements are crit-
ical to its proper treatment. Virtually all digital BP monitors
sold within the past decade use the oscillometric technique
to measure BP. The replacement of mercury sphygmoma-
nometers with electronic sphygmomanometers has become
common [9]. A device that can pass the AAMI standard
testing [3] with reliable accuracy would be desirable in the
research and clinical settings.
The HBP-1300 has built-in auscultatory and oscillometric
functionality for measuring BP. In the current study, the
oscillometric model was tested according to the AAMI
protocol. The auscultatory model reflects the habits of clin-
ical physicians in the clinical setting. In the end, the average
difference between the two doctors was very low. The
Bland-Altman plots showed narrow differences between
the observers and the device, and no important differences
were observed over the measured BP ranges.
In many parts of the world, healthcare facilities and regu-
latory bodies require testing according to the British Hyper-
tension Society (BHS) protocol [10]. The BHS protocol is
not a standard like the AAMI document. The BHS data
analyses result in grades of A, B, C, or D depending on the
error percentages within ±5, ±10, and ±15 mmHg com-
pared with the observer data. To achieve the highest grade,
A, on the BHS protocol data analysis, at least 60, 85, and 95
% of the error readings must be within 5, 10, and 15
mmHg, respectively, from each chosen observer value. The
spot device mean SBP error was -1.3 ± 3.6 mmHg: 84.7 %
of the error readings were within ±4 mmHg, 98 % were
within ±5 mmHg, and 100 % were within ±10 mmHg. All
of the SBP values passed AAMI requirements. For DBP, the
mean error was 0.7 ± 3.8 mmHg: 85.9 % of the DBP errors
were within ±4 mmHg, 98.4 % within ±10 mmHg, and 100
% were within ±15 mmHg. All of the values exceeded the
AAMI minimum requirements (passed method 1). The
tested device should be useful in various sites of medical-
care delivery because of its accuracy.
According to ISO 81060-2: 2013 the Criterion1 uses the
255 individual test - REFERRENCE differences to deter-
mine the performance of the SPHYGMOMANOMETER –
UNDER - TEST. As a result, the calculated standard devi-
ation, sn (or precision) will reflect both intra-subject and
inter-subject variability. However, the allowable standard
deviation is constant even when the mean of difference,
mean of n (or bias) is large. Criterion uses the average of
the differences from each subject, so the calculated sm
reflects only inter subject variability, and a large intra –
subject variability can still pass this method. Criterion 2
attempts to prevent that by reducing the allowable sn as n
increases, (sn = 8.00mmHg versus sm = 6.95mmHg), thus
addressing both bias and inter-subject precision. In this
manuscript both the criterions were used to test the valid-
ation of this sphygmomanometer and it has passed the
request of both the criterions successfully.
Conclusion
The professional BP monitor Omron HBP-1300 is desirable
for measuring the BP for Chinese children and adults.
Availability of supporting data
The database has been uploaded as a supplementary
material file on the website.
Additional file
Additional file 1: Validation of OMRON-1300 database. 85 subjects
and 51 variables were included in the database, ‘NO’ represented the
identify number, ‘A’ represented the 1st examiner, and ‘B’ represented
the 2nd examiner, ‘SBP’ was systolic blood pressure, ‘DBP’ was diastolic
blood pressure, ‘1’ to ‘7’ represented the times of measurements, ‘HR’
was heart rates per minute, ‘SEX’ was the gender, ‘AGE’ was the age of
the subjects. (XLSX 24 kb)
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